Status:

RECRUITING

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

Lead Sponsor:

The Rogosin Institute

Collaborating Sponsors:

New York Presbyterian Hospital

Weill Medical College of Cornell University

Conditions:

Kidney Diseases

Kidney Failure, Chronic

Eligibility:

All Genders

18+ years

Brief Summary

A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmu...

Detailed Description

RENAL AID is designed as an inclusive data and tissue repository that is capable of linking demographic, clinical, laboratory, histology, genetic and radiographic data into one interconnected electron...

Eligibility Criteria

Inclusion

  • Key Inclusion Criteria:
  • All Groups:
  • Males or females
  • 18 years of age and older
  • Willing and able to provide informed consent
  • Native Biopsy Tissue Group:
  • \- Require an initial kidney biopsy for medical necessity
  • Native Kidney, Non-tissue Group:
  • Previously had a kidney biopsy and the tissue is not stored in this biorepository; or
  • Have diabetes and kidney disease and have not had a kidney biopsy
  • Allograft Tissue Group:
  • \- Have undergone a renal transplant and require a transplant biopsy for either surveillance or "for-cause" indications.
  • Key Exclusion Criteria for all Groups:
  • \- Inability to provide informed consent.

Exclusion

    Key Trial Info

    Start Date :

    February 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2028

    Estimated Enrollment :

    2000 Patients enrolled

    Trial Details

    Trial ID

    NCT01802034

    Start Date

    February 1 2013

    End Date

    August 1 2028

    Last Update

    April 4 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    The Rogosin Institute

    New York, New York, United States, 10021